Department of Pathology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada.
Cell Transplant. 2012;21(12):2797-804. doi: 10.3727/096368912X653273. Epub 2012 Aug 27.
β-Cell replacement therapy by either whole-organ pancreas or islets of Langerhans transplantation can restore carbohydrate control to diabetic patients and reduces complications associated with the disease. One of the variables inherent in islet transplantation is the isolation of functional islets from donor pancreata. Islet isolations fail to consistently produce good-quality functional islets. A rapid pretransplant assay to determine posttransplant function of islets would be an invaluable tool. We have tested the novel hypothesis that modified oxygen consumption rates (OCR), standardized to DNA quantity (nmol/min-mg DNA), would serve as a pretransplant assessment of the metabolic potency of the islets postisolation. This study compares the ability of current in vitro assays to predict in vivo restoration of normoglycemia in a diabetic nude mouse posttransplantation of adult pig islets. There is known to be a diversity of islet sizes within each preparation. This parameter has not heretofore been effectively considered a critical factor in islet engraftment. Our results suggest a surprising finding that islet size influences the probability of restoring carbohydrate control. Based on this observation, we thus developed a novel predictor of islet graft function that combines the effects of both islet OCR and size. When OCR was divided by the islet index (size), a highly significant predictor of graft function was established (p = 0.0002, n = 75). Furthermore, when OCR/islet index values exceeded 70.0 nmol/min-mg DNA/islet index, an effective threshold of diabetes reversal was observed. This assay can be performed with as few as 1,000 islet equivalents (IEQ) and conducted in less than 60 min. Our data suggest that, using this novel method to assess islet cell function prior to transplantation, OCR/islet index thresholds provide a valuable tool in identifying which islet preparations are most likely to restore glycemic control posttransplant.
通过整个胰腺或胰岛移植进行β细胞替代治疗,可以使糖尿病患者恢复碳水化合物控制,并减少与该疾病相关的并发症。胰岛移植固有的一个变量是从供体胰腺中分离出功能胰岛。胰岛分离未能始终如一地产生高质量的功能胰岛。一种快速的移植前检测方法来确定胰岛移植后的功能将是一个非常有价值的工具。我们已经测试了一个新的假设,即经过修饰的耗氧量(OCR),标准化为 DNA 量(nmol/min-mg DNA),可以作为胰岛分离后胰岛代谢潜力的移植前评估。本研究比较了当前的体外检测方法,以预测成年猪胰岛移植后糖尿病裸鼠体内血糖恢复正常的能力。已知每个胰岛制剂中都存在胰岛大小的多样性。到目前为止,这个参数尚未被有效地认为是胰岛移植的关键因素。我们的研究结果表明了一个令人惊讶的发现,即胰岛大小会影响恢复碳水化合物控制的可能性。基于这一观察结果,我们因此开发了一种新的胰岛移植物功能预测方法,该方法结合了胰岛 OCR 和大小的影响。当 OCR 除以胰岛指数(大小)时,建立了一个高度显著的移植物功能预测因子(p = 0.0002,n = 75)。此外,当 OCR/胰岛指数值超过 70.0 nmol/min-mg DNA/胰岛指数时,观察到有效的糖尿病逆转阈值。这种检测方法可以用少至 1000 个胰岛当量(IEQ)进行,并且可以在不到 60 分钟内完成。我们的数据表明,使用这种新方法在移植前评估胰岛细胞功能,OCR/胰岛指数阈值为确定哪些胰岛制剂最有可能在移植后恢复血糖控制提供了一个有价值的工具。